Efficacy of sodium-glucose co-transporter-2 inhibitors in patients with heart failure
Open Access
- 17 February 2021
- journal article
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 26 (1), 4235
- https://doi.org/10.15829/1560-4071-2021-4235
Abstract
В статье проанализированы новые результаты рандомизированных клинических исследований по применению ингибиторов натрий-глюкозного ко-транспортера 2 типа у пациентов с сердечно-сосудистыми заболеваниями, хронической сердечной недостаточностью с сахарным диабетом 2 типа и без него. Более подробно освещены данные последних исследований EMPEROR reduced, VERTIS CV, SOLOIST-WHF, SCORED.This publication has 30 references indexed in Scilit:
- Canagliflozin and Cardiovascular and Renal Events in Type 2 DiabetesThe New England Journal of Medicine, 2017
- Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat heartsFree Radical Biology & Medicine, 2017
- Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trialsDiabetes, Obesity and Metabolism, 2017
- Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbitsDiabetologia, 2016
- Effects of diuretics on sodium-dependent glucose cotransporter 2 inhibitor-induced changes in blood pressure in obese rats suffering from the metabolic syndromeJournal of Hypertension, 2016
- Sodium–glucose cotransporter 2 inhibition and cardiovascular risk reduction in patients with type 2 diabetes: the emerging role of natriuresisKidney International, 2016
- Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME®trialEuropean Heart Journal, 2016
- Sodium-glucose cotransporter 2 inhibition and health benefits: The Robin Hood effectIndian Journal of Endocrinology and Metabolism, 2016
- A new principle of the treatment of type 2 diabetes mellitus by stimulation of glucosuriaProblemy Endokrinologii, 2012
- Rol' Na-H obmennika v patogeneze sakharnogo diabeta 2 tipaDiabetes mellitus, 2001